Company Filing History:
Years Active: 2006-2011
Title: Innovations by Inventor Sean Scott
Introduction
Sean Scott is a notable inventor based in San Francisco, CA, who has made significant contributions to the field of neurodegenerative disease treatment. With a total of five patents to his name, Scott's work focuses on innovative methods for modulating proteasome activity and addressing conditions such as amyotrophic lateral sclerosis (ALS).
Latest Patents
One of Sean Scott's latest patents involves the treatment of neurodegenerative diseases using proteasome modulators. This invention provides methods for modulating proteasome activity in a subject by administering a therapeutically effective amount of a proteasome modulating pharmacological agent. In a preferred embodiment, the agent is a protease inhibitor. Additionally, a screening assay for detecting and identifying these pharmacological agents is included. Another significant patent addresses the use of difluoromethylornithine (DFMO) for treating ALS. This invention outlines methods and compositions for modulating polyamine pathway activity to ameliorate neurodegenerative disorders. It specifically focuses on inhibiting the enzyme ornithine decarboxylase (ODC) to lower polyamine levels, which can have beneficial effects on ALS symptoms.
Career Highlights
Throughout his career, Sean Scott has worked with various organizations, including the Als Therapy Development Foundation, Inc. and Pathologica LLC. His innovative approaches have positioned him as a key figure in the research and development of treatments for neurodegenerative diseases.
Collaborations
Scott has collaborated with notable professionals in his field, including Tennore M Ramesh and Laurence J Marton. These collaborations have further enhanced his research and contributions to the scientific community.
Conclusion
Sean Scott's work exemplifies the impact of innovation in the treatment of neurodegenerative diseases. His patents and career achievements highlight his dedication to advancing medical science and improving patient outcomes.